Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
New Lipid Lowering Therapies For Cardiovascular and Metabolic Diseases : : Lessons From The Past and Future Challenges / / Ahmed Bakillah
| New Lipid Lowering Therapies For Cardiovascular and Metabolic Diseases : : Lessons From The Past and Future Challenges / / Ahmed Bakillah |
| Autore | Bakillah Ahmed |
| Pubbl/distr/stampa | MDPI - Multidisciplinary Digital Publishing Institute, 2019 |
| Descrizione fisica | 1 electronic resource (116 p.) |
| Soggetto topico | Biology, life sciences |
| Soggetto non controllato |
apolipoprotein
lipids risk stratification proprotein convertase subtilisin-kexin type 9 (PCSK9) vaspin sphingolipids PCSK9 ceramides atrial fibrillation circular RNA STEMI cholesterol lipoproteins cardiovascular disease (CVD) coronary artery bypass grafting atherosclerosis statin LDL subfractions acute kidney injury dyslipidemia gene expression NSTEMI NAFLD hyperlipidemia nonstatin cholesteryl ester transfer protein low-density lipoprotein cholesterol anacetrapib HDL acute coronary syndrome miRNA cardiovascular risk pleiotropic actions genetic ABCA1 sdLDL cardiovascular disease proprotein convertase subtilisin/kexin type 9 inclisiran reverse cholesterol transport sterol small interfering RNA (siRNA) RNA-binding proteins cardiovascular diseases NASH low-density lipoprotein-cholesterol (LDL-C) stroke nutrigenetics type 2 diabetes statins sphingomyelin hepatic fibrosis diabetes |
| ISBN |
9783039216772
3039216775 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910367751903321 |
Bakillah Ahmed
|
||
| MDPI - Multidisciplinary Digital Publishing Institute, 2019 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Novel Biomarkers for Heart Disease
| Novel Biomarkers for Heart Disease |
| Autore | Lichtenauer Michael |
| Pubbl/distr/stampa | Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020 |
| Descrizione fisica | 1 online resource (420 p.) |
| Soggetto topico | Medicine |
| Soggetto non controllato |
acute kidney injury
acute myocardial infarction AMI aneurysm aortic disease aortic regurgitation atrial fibrillation atrial myopathy biomarker biomarkers carbohydrate antigen-125 cardiac biomarkers cardiac intensive care units cardiac magnetic resonance imaging cardiometabolic disease cardiometabolic risks cardiovascular death cardiovascular diseases cardiovascular events cardiovascular risk cardiovascular surgery catestatin cell adhesion molecule ceramides ceruloplasmin chronic heart failure chronic kidney disease circulating cells circulating miRNAs CKD cohort studies coronary artery disease CVD diet quality echocardiography ejection fraction epicardial adipose tissue epicardial fat epicardial fat volume FABP3 fatty acid-binding protein 3 Framingham risk score GDF-15 GDF8 growth differentiation factor 15 (GDF-15) H-FABP healthy eating index heart failure heart failure decompensation heart-type fatty acid-binding protein heart-type fatty acid-binding protein (H-FABP) herat failure HF HFpEF HFrEF hypertension inflammatory marker KLF4 left ventricular adverse remodelling left ventricular ejection fraction left ventricular systolic function liver-type fatty-acid-binding protein long-term outcomes longitudinal strain magnetic resonance imaging magnetic resonance spectroscopy metabolic syndrome microRNA miRNA mitochondrial DNA (mtDNA) mitochondrial dysfunction muscle wasting myocardial infarction myocardial triglyceride content myostatin n/a NAFLD NAFLD fibrosis score NT-proBNP NYHA functional class obesity older women operative risk oxidative stress PBMCS Pentraxin-3 platelets PPCI pregnancy-associated plasma protein-A primary prevention reactive oxygen species (ROS) renal dysfunction repeated measurements risk prediction risk stratification saliva salivary biomarkers sarcopenia secondary prevention SOCE soluble suppression of tumorigenicity 2 (sST2) soluble urokinase-type plasminogen activator receptor (suPAR) sST2 STEMI STIM1 sudden cardiac death suPAR synthetic phenotype T1 mapping TGF-β pathway thyroid-stimulating hormone troponin vena contracta area ventricular arrhythmia ventricular tachycardia very low-density lipoprotein |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910557546203321 |
|
Lichtenauer Michael
|
||
| Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||